Gyre Therapeutics ("Gyre") (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies across organ systems affected by chronic disease, ...
ITAT Pune ruled that the late filing of the Form 10B audit report is not fatal to the charitable trust exemption if filed before assessment completion. The court reversed the disallowance of ...
Expensify reported a slight dip in third-quarter revenue year over year amid continued growth of its new travel offering as well as progress in migrating clients to the "New Expensify." ...
Q3 2025 Earnings Call November 6, 2025 5:00 PM ESTCompany ParticipantsRyan Schaffer - CFO & DirectorNiki WallrothDavid Barrett ...
TipRanks on MSN
Expensify Reports Q3 2025 Financial Results
Expensify, Inc. ( ($EXFY) ) has released its Q3 earnings. Here is a breakdown of the information Expensify, Inc. presented to its investors.
Expensify launches hybrid 'contextual' AI expense agent; Forwardly announces AI bill pay system; Patriot Software introduces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback